Imidiazole derivatives and their use as agonists selective at alpha 2B or 2B/2C adrenergic receptors

Details for Australian Patent Application No. 2002254265 (hide)

Owner Allergan, Inc.

Inventors Garst, Michael E.; Gil, Daniel W.; Burke, James A.; Harcourt, Dale A.; Munk, Stephen A.; Heidelbaugh, Todd M.; Chow, Ken; Wheeler, Larry A.; Gomez, Dario G.

Agent Davies Collison Cave

Pub. Number AU-B-2002254265

PCT Pub. Number WO2002/076950

Priority 09/815,362 21.03.01 US

Parent 744798

Filing date 13 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 15 May 2008

International Classifications

C07D 233/58 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/538 (2006.01)

A61P 1/12 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/12 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 Drugs for disorders of the senses

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002254265

1 May 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Garst, Michael E.; Gil, Daniel W.; Burke, James A.; Harcourt, Dale A.; Munk, Stephen A.; Heidelbaugh, Todd M.; Chow, Ken; Wheeler, Larry A. and Gomez, Dario G.

15 May 2008 Application Accepted

  Published as AU-B-2002254265

11 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254266-CLOSED LOOP DRUG DELIVERY SYSTEM AND REMOTE MANAGEMENT THEREOF

2002254264-METHOD AND SYSTEM FOR TRANSCODING VIDEO AND SPEECH SIGNALS